Nu Skin Enterprises, Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Wellness at $689.1 million, 46% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1,375
|
1,485
|
1,732
|
1,969
|
2,226
|
2,696
|
2,582
|
2,420
|
2,679
|
2,279
|
2,208
|
| Wellness |
—
|
689
-9.0%
share 46.4%
|
757
-14.5%
share 43.7%
|
886
-10.7%
share 45.0%
|
992
-6.6%
share 44.6%
|
1,063
+15.2%
share 39.4%
|
923
+6.9%
share 35.7%
|
863
-6.3%
share 35.7%
|
921
+12.7%
share 34.4%
|
817
share 35.9%
|
—
|
| Devices And Related Consumables |
—
|
—
|
—
|
—
|
—
|
658
-7.6%
share 24.4%
|
712
+15.2%
share 27.6%
|
618
share 25.5%
|
—
|
—
|
—
|
| Beauty |
—
|
568
-16.7%
share 38.3%
|
682
-20.6%
share 39.4%
|
859
-19.7%
share 43.6%
|
1,070
-25.9%
share 48.1%
|
1,443
-3.3%
share 53.5%
|
1,492
+4.8%
share 57.8%
|
1,423
-14.2%
share 58.8%
|
1,660
+14.0%
share 62.0%
|
1,456
share 63.9%
|
—
|
| Other Product Lines |
—
|
228
-22.2%
share 15.4%
|
293
+30.6%
share 16.9%
|
224
+37.2%
share 11.4%
|
164
-14.1%
share 7.4%
|
190
+13.7%
share 7.1%
|
168
+25.2%
share 6.5%
|
134
+36.6%
share 5.5%
|
98
+1686.3%
share 3.7%
|
5
share 0.2%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- NUS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Provo, UT
- SEC filer status
- Accelerated filer
- SEC CIK
- 1021561
- Former names
- NU SKIN ENTERPRISES INC (until Sep 13, 2019); NU SKIN ASIA PACIFIC INC (until Aug 13, 1998); NU SKIN ASIA INC (until Sep 16, 1996)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.